Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
30.4M
-
Shares change
-
+2.52M
-
Total reported value, excl. options
-
$1.2B
-
Value change
-
+$118M
-
Put/Call ratio
-
0.13
-
Number of buys
-
53
-
Number of sells
-
-44
-
Price
-
$39.52
Significant Holders of Biohaven Pharmactl Hldg Co L - COM (BHVN) as of Q2 2018
127 filings reported holding BHVN - Biohaven Pharmactl Hldg Co L - COM as of Q2 2018.
Biohaven Pharmactl Hldg Co L - COM (BHVN) has 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.4M shares
.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (3.3M shares), PERCEPTIVE ADVISORS LLC (2.74M shares), BlackRock Inc. (2.09M shares), Vivo Capital, LLC (2.05M shares), ALLIANCEBERNSTEIN L.P. (1.8M shares), STATE STREET CORP (1.49M shares), JPMORGAN CHASE & CO (1.43M shares), VHCP Management II, LLC (1.42M shares), FMR LLC (1.35M shares), and WELLINGTON MANAGEMENT GROUP LLP (1.08M shares).
This table shows the top 99 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.